169252 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses; Viruses Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
Sexually Transmitted Infection Testing from Human Dried Blood Spots Collected Remotely
#2DETECTION OF ANTI-VIRAL CDR3s IN CANCER
#3CYTOMEGALOVIRUS T CELL EPITOPES AND USES THEREOF
#4THERAPEUTIC AND DIAGNOSTIC AGENTS AND USES THEREOF
#5APPLICATION OF HCMV GP34- AND GP68-SPECIFIC ANTIBODIES AND FRAGMENTS THEREOF FOR PREVENTION, THERAPY AND DIAGNOSTICS OF HCMV DISEASE
#6HSV VECTORS
#7HERPES SIMPLEX VIRUS TYPES 1 AND 2 LATERAL FLOW ASSAY
#8THERMODYNAMIC PREDICTION
#9Lateral Flow Assay Device and Method for Rapid Detection of Antibodies Against Felis Catus Gammaherpesvirus 1 in Domestic Cat Blood
#10Methods and compositions for assessing antibody specificities
#11ANTIBODIES AND METHODS FOR THE DIAGNOSIS, PREVENTION, AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION
#12NOVEL SEROLOGY ASSAY FOR THE DETECTION OF PORCINE VIRUSES
#13METHODS FOR MODULATING HOST CELL SURFACE INTERACTIONS WITH HUMAN CYTOMEGALOVIRUS
#14Methods and compositions for assessing antibody specificities
#15METHOD FOR DETECTION AND QUANTITATIVE MONITORING OF INFECTIONS WITH HERPESVIRUSES
#16METHODS AND COMPOSITIONS FOR ASSESSING ANTIBODY SPECIFICITIES
#17EPSTEIN-BARR VIRUS MONOCLONAL ANTIBODIES AND USES THEREOF
#18HSV gE ANTIBODIES
#19METHODS FOR TREATING AND PREVENTING CYTOMEGALOVIRUS INFECTION
#20ANTI-GLYCOPROTEIN D ANTIBODIES, METHODS OF PREPARATION, AND USES THEREOF
#21METHOD FOR DETECTING CYTOMEGALOVIRUS (CMV) AND MEASURING AND QUANTIFYING PENTAMERIC COMPLEX USING AN INDIRECT SANDWICH ELISA
#22Assay to Differentiate Natural CMV Infection from CMV Vaccines that Lack UL144
#23Low-Cost Rapid Diagnostic Biosensors
#24ANTIBODIES
#25RNA DETERMINANTS FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL INFECTIONS
#26DIAGNOSIS OF CONGENITAL CYTOMEGALOVIRUS INFECTION
#27NOVEL ANTIBODIES FOR DETECTING EPSTEIN BARR VIRUS-POSITIVE GASTRIC CANCER
#28SYSTEMS AND METHODS FOR DETECTING SUBSTANCES IN A FLUID USING TAPERED FIBERS
#29METHOD FOR DIAGNOSING AND STAGING HERPESVIRUS-MEDIATED NEURODEGENERATION
#30MHC Class I Associated Hepatitis B Peptides
#31Classification and Treatment of Gastric Cancer
#32Antibodies and methods for the diagnosis and treatment of hepatitis b virus infection
#33Monoclonal antibody 11B2C7 or fragment thereof, that specifically recognizes herpes simplex virus 1 and 2
#34Monoclonal antibody 14F5F6 or fragment thereof, that specifically recognizes herpes simplex virus 1 and 2
#35Anti-varicella-zoster virus antibody, immunological measurement method, and immunological measurement device
#36Methods for detecting antiviral-drug resistant virus
#37Antibodies and methods for the diagnosis, prevention, and treatment of Epstein Barr virus infection
#38Methods and compositions for assessing antibody specificities
#39METHODS AND COMPOSITIONS FOR ASSESSING ANTIBODY SPECIFICITIES
#40Detection of an antibody against a pathogen
#41Antibody to Epstein Barr Virus and Uses Thereof
#42SYSTEMS and METHODS for DETECTING INFECTIOUS DISEASES
#43MVA-gH/gL-PC vaccine derived antibodies neutralizing human cytomegalovirus infectivity and methods thereof
#44Diagnosis and treatment of viral diseases
#45SYSTEMS and METHODS for DETECTING INFECTIOUS DISEASES
#46Methods and compositions for assessing antibody specificities
#47TRAIL-BASED ENCEPHALITIS DIFFERENTIATION DIAGNOSIS METHOD AND THE APPARATUS FOR THE SAME
#48Sweat as a biofluid for analysis and disease identification
#49RNA determinants for distinguishing between bacterial and viral infections
#50MHC class I associated hepatitis B peptides
#51Truncated glycoprotein G of herpes simplex virus 2
#52Enzyme-linked immunoassay to detect gammaherpesvirus 1
#53IMMUNOCHROMATOGRAPHIC ANALYSIS DEVICE FOR DETECTING VARICELLA-ZOSTER VIRUS
#54Method for reduction of interferences in immunoassays
#55VIRAL BIOMARKERS AND USES THEREFOR
#56Anti-BARF1 monoclonal antibody
#57MVA-gh/gL-PC vaccine derived antibodies neutralizing human cytomegalovirus infectivity and methods thereof
#58Diagnosis and treatment of viral diseases
#59Methods and compositions for treating herpes
#60Method for assessing risk of human cytomegalovirus active infection in body and related kit
#61Antigenic epitopes from EBV gp350/220 and uses thereof
#62Diagnosis and treatment of viral diseases
#63Systems and methods for detecting infectious diseases
#64Method of diagnosing and treating Epstein Barr virus-based myalgic encephalomyelitis chronic fatigue syndrome patients
#65Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (miR145) and micro-RNA 212 (miR212)
#66Compositions and methods for immunodominant antigens
#67Enhancing serological assays via fusion proteins
#68Compositions and methods for immunodominant antigens of
#69MHC class I associated peptides for prevention and treatment of hepatitis B virus infection
#70Detection of an antibody against a pathogen
#71EPITOPES OF HERPES SIMPLEX VIRUS
#72Rapid and sensitive serological assay to determine if patients are infected with herpes simplex virus type 1 HSV-1 and/or type 2 HSV-2
#73METHOD OF DIAGNOSING AND TREATING EPSTEIN BARR VIRUS-BASED MYALGIC ENCEPHALOMYELITIS CHRONIC FATIGUE SYNDROME PATIENTS USING A SERUM ANTIBODY ASSAY
#74EBV PROTEINS AS MARKERS IN METHODS OF DIAGNOSING CHRONIC FATIGUE SYNDROME (CFS)
#75Cell model for neovascular diseases using EBV-infected human corneal epithelial cells
#76Systems and methods for detecting infectious diseases
#77Composition comprising at least two influenza A virus-neutralizing-binding molecules
#78Diagnosis and treatment of viral diseases
#79METHOD FOR RECOGNITION OF A PRESENCE OF AN INFECTION WITH CMV
#80Systems and methods for detecting infectious diseases
#81PRODUCTION OF A HCMV BASED VACCINE IN HUMAN AMNIOCYTE CELL LINES
#82Protein microarray for characterizing the specificity of the monoclonal immunoglobulins of MGUS or myeloma patients
#83COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF CYTOMEGALOVIRUS INFECTIONS
#84COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF CYTOMEGALOVIRUS
#85Anti-Human Cytomegalovirus Antibodies And Use Thereof
#86Systems and methods for detecting infectious diseases
#87Systems and methods for detecting infectious diseases
#88Preassembled hybrid nanocluster plasmonic resonator for immunological detection and serotyping of virus and microbes
#89METHOD OF INTRACELLULAR INFECTIOUS AGENT DETECTION IN SPERM CELLS
#90APPARATUS, METHODS, AND APPLICATIONS FOR POINT OF CARE MULTIPLEXED DIAGNOSTICS
#91Use of at least one biomarker for the in vitro prognosis or diagnosis of lymphoproliferative episodes associated with the Epstein-Barr virus (EBV)
#92Herpes simplex virus vaccines
#93DIAGNOSIS AND TREATMENT OF VIRAL DISEASES
#94Genetic variant of cytomegalovirus (CMV)
#95Biomarkers for prenatal diagnosis of congenital cytomegalovirus
#96Guinea pig cytomegalovirus (CIDMTR strain)
#97METHOD OF DIAGNOSING AND TREATING EPSTEIN BARR VIRUS-BASED MYALGIC ENCEPHALOMYELITIS CHRONIC FATIGUE SYNDROME PATIENTS
#98Assay method for peptide specific T-cells
#99Idiotypic antibodies and uses thereof
#100Modulation of UL24 interactions with protein targets and uses thereof for inhibition of herpesvirus infection
#101USE OF HISTONES FOR THE EARLY DIAGNOSIS AND/OR PREVENTIVE THERAPY OF VIRALLY-INFECTED LIVING CELLS AND A BIOCHIP FOR CARRYING OUT SAID DIAGNOSIS
#102Method for Producing T Cell Receptor-Like Monoclonal Antibodies and Uses Thereof
#103Photo-Inactivated Viruses and Systems and Methods of Using the Same
#104Herpes simplex virus vaccines
#105Compositions and methods for the therapy and diagnosis of cytomegalovirus infections
#106Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (mi145) and micro-RNA 212 (miR212)
#107Compositions and methods for immunodominant antigens of
#108Method for detecting antibody against SITH-1 in biological sample
#109Method for detecting substance in biological sample
#110Compositions and methods for the therapy and diagnosis of cytomegalovirus
#111Serological screening for HHV-8 infection using antigen mixtures
#112METHODS FOR THE DIAGNOSIS OF VARICELLA ZOSTER VIRUS INFECTION
#113Compositions and methods for immunodominant antigens of
#114Methods of identifying a modulator that inhibits the binding between Epstein-Barr virus induced receptor 2 and cholesterol derived ligands
#115USE OF SYNTHETIC PEPTIDE DERIVED FROM ZEBRA PROTEIN FOR THE IN VITRO DIAGNOSIS OF THE EPSTEIN-BARR VIRUS (EBV) REACTIVATION
#116METHOD AND KIT FOR DETECTION/IDENTIFICATION OF VIRUS-INFECTED CELL
#117NOVEL TOOL FOR THE ANALYSIS OF NEURAL CIRCUITS
#118Methods and compositions for detecting herpes simplex virus type 2
#119METHODS FOR ASSESSING FATIGUE LEVEL AND APPLICATIONS THEREOF
#120Biomarkers for prenatal diagnosis of congenital cytomegalovirus
#121ANALYTE MANIPULATION AND DETECTION
#122Assay method for peptide specific T-cells
#123Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
#124Compositions and methods for immunodominant antigens
#125Compositions and methods for the therapy and diagnosis of cytomegalovirus
#126Preparation for the Prevention and/or Treatment of a Tissue Change of Mesenchymal Origin
#127Compositions and methods for immunodominant antigens of
#128COMPOSITIONS AND METHODS FOR DETECTION AND TREATMENT OF HUMAN HERPESVIRUS (HHV)-6
#129Methods for assessing fatigue level and applications thereof
#130Microarray-mediated diagnosis of herpes virus infection by monitoring host's differential gene expression upon infection
#131SPECIFIC BINDING AGENTS FOR KSHV vIL-6 THAT NEUTRALIZE A BIOLOGICAL ACTIVITY
#132Herpes Virus-Based Compositions and Methods of Use
#133ASSAYS FOR PREDICTING AND ASSESSING PREDISPOSITION TO MALE PATTERN BALDNESS
#134Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
#135Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
#136Chromatographic Analysis Devices And Test Kits
#137Specific binding agents for KSHV vIL-6 that neutralize a biological activity
#138Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
#139Methods for the determination of antibody IgG avidity
#140Detection of multiple anti-viral antibodies
#141Specific binding agents for KSHV vIL-6 that neutralize a biological activity
#142Method for inhibiting the replication of herpes viruses
#143Methods and compositions for detecting herpes simplex virus type 2
#144Multiplex flow assays preferably with magnetic particles as solid phase
#145Multiplex flow assays preferably with magnetic particles as solid phase
#146Rapid diagnostic assay
#147Rapid diagnostic assay
#148Peptides derived from capsid antigens of the Epstein-Barr virus and the use thereof
#149Specific binding agents for KSHV vIL-6 that neutralize a biological activity
#150Screening methods for identifying inhibitors of herpesviral replication
#151Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
#152Multiplex flow assays preferably with magnetic particles as solid phase
#153Peptide from the glycoprotein B from human herpesvirus 7 for use in a serological ELISA test
#154Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
#155Methods and compositions for modulating herpesviral replication and transcription activator
#156Single cell assessment of viral infection/replication
#157Method of using physiological markers to estimate cardiovascular risk
#158Methods for improving analyte detection using photochemical reactions